Navigation Links
Researchers investigate mechanism of Alzheimer's therapy
Date:7/8/2013

LEXINGTON, Ky. -- Researchers at the University of Kentucky Sanders-Brown Center on Aging, led by faculty member Donna Wilcock, have recently published a new paper in the Journal of Neuroscience detailing an advance in treatment of Alzheimer's disease.

Gammagard IVIg is a therapy that has been investigated for treatment of Alzheimer's. Despite small clinical studies that have reported efficacy of the approach, the mechanism of action is poorly understood.

The UK researchers set out to investigate the mechanism by which the treatment may act in the brain to lower amyloid deposition (amyloid deposits being a key pathology in Alzheimer's).

To conduct their investigation, researchers introduced IVIg directly into the brains of mice which carry a human gene causing them to develop amyloid plaques. They found that IVIg lowers amyloid deposits in the brains of the mice over the course of seven days. Their data suggest that the modulation of inflammation in the brain by IVIg is a key event that leads to the reduction in amyloid deposition.

The scientists hypothesize that the IVIg acts as an immune modulator, and this immune modulation is responsible for the reductions in amyloid pathology.

The data suggests that modulating the immune response in the brain may help ameliorate the Alzheimer's pathology. Researchers are currently investigating other ways to produce the same modulation of the immune response because the access of IVIg to the brain when administered peripherally is very limited.


'/>"/>

Contact: Allison Elliott-Shannon
allison.elliott@uky.edu
University of Kentucky
Source:Eurekalert

Page: 1

Related medicine news :

1. Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
2. Researchers use immunocytochemistry to determine ALK status
3. Researchers find 2 new methods to determine ALK status
4. CWRU researchers trace inner-city womens health issues to childhood traumas
5. Penn Medicine researchers discover link between fear and sound perception
6. UCI researchers awarded $2.27 million to create novel diabetes treatments
7. MS researchers determine that brain reserve independently protects against cognitive decline in MS
8. Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers
9. PhD Thesis Writing Expands the Scope of its Services for Doctoral Researchers
10. Researchers Identify New Genes Linked to the Origins of Alzheimer’s, Says Cure Alzheimers Fund
11. Researchers identify master coordinator for aortic rupture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... NY (PRWEB) , ... February 22, 2017 , ... ... life and athletics. It’s enough to overwork even the sharpest brain. , Power ... offer peak healthy activity without over clocking the brain. Each capsule contains Cognizin® ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... and eligibility requirements effective with the April 2017 testing period. NACCM, a nonprofit ... “The Care Manager Certified (CMC) exam is periodically re-calibrated to ensure that newly ...
(Date:2/22/2017)... ... February 22, 2017 , ... A cylindrical ... and sometimes harder to reach ones, according to the results of a clinical ... Conference in Houston by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist ...
(Date:2/22/2017)... ... February 22, 2017 , ... The ... today, as organizations, advocates, and individuals join together to increase recognition about the ... ultimately save lives. , “Today we mark a nationwide movement to raise awareness ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... BOTHELL, Wash. and VANCOUVER, British ... Inc. (NASDAQ: OGXI ) today announced its ... Events In January 2017, OncoGenex, and Achieve ... announced that they have entered into a definitive merger ... all-stock transaction. Upon completion of the proposed merger, Achieve,s ...
(Date:2/23/2017)... CAMBRIDGE, England and DEERFIELD, Ill. ... U.S.A. , Inc., a wholly-owned subsidiary ... Limited, a joint venture between Cambridge Cognition Holdings PLC ... the use of a specially designed app on an ... in patients with Major Depressive Disorder (MDD). ...
(Date:2/22/2017)... , Feb. 22, 2017 General Report ... Market Value & Growth Trends - Market Drivers ... Analysis for each chapter segment - Section on ... full report: https://www.reportbuyer.com/product/4665946/ This ... delivery methods: articulated arm lasers, fiber-delivered lasers and ...
Breaking Medicine Technology: